Mitchell Sinkler & Starr PA raised its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 118.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,277 shares of the medical technology company’s stock after acquiring an additional 15,876 shares […]
Mitchell Sinkler & Starr PA grew its stake in shares of Oracle Co. (NYSE:ORCL – Free Report) by 13.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,048 shares of the enterprise software provider’s stock after buying an additional 7,255 shares […]
Mitchell Sinkler & Starr PA raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 29.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 155,121 shares of the healthcare product maker’s stock after purchasing an additional 35,131 shares during the quarter. Abbott Laboratories […]
Mitchell Sinkler & Starr PA boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 67.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,161 shares of the company’s stock after acquiring an additional 5,704 shares during the […]
Mitchell Sinkler & Starr PA boosted its position in shares of Chevron Co. (NYSE:CVX – Free Report) by 28.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,223 shares of the oil and gas company’s stock after buying an additional 7,283 […]